Dr Reddy's Labs rallied 1.5 percent as the company launched its Memantine hydrochloride tablets (a generic version of Namenda) in the US while Sun Pharma slipped half a percent as sources told CNBC-TV18 that USFDA has audited company's API facility in Ahmednagar, Maharashtra.
The Reserve Bank is likely to cut benchmark interest rate by 0.25 percent in its next month's policy review if monsoon rains remain normal, Bank of America Merrill Lynch said on Monday.
Note: Any changes made to your Portfolio today will be effective only in the next day's Networth mailer.
No comments:
Post a Comment